Ironwood Financial’s Immunogen Inc IMGN Stock Holding History

Ironwood Financial’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47	Closed	–	–	580
2021 Q3	$0	Hold	47	–	–	﹤0.01%	611
2021 Q2	$0	Hold	47	–	–	﹤0.01%	596
2021 Q1	$0	Buy	+47	New	+$384	﹤0.01%	580

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ironwood Financial's IMGN Position: Q4 2021 in Review

Ironwood Financial sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 47 shares.

Ironwood Financial first reported a position in IMGN in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Ironwood Financial reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 47 Immunogen Inc shares in Q4 2021.
Ironwood Financial first reported a position in Immunogen Inc in Q1 2021 and held it in 3 quarters.
Ironwood Financial's Immunogen Inc position peaked at $0 in Q3 2021.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.